Pesquisas alternativas:
treat compared » treated compared (Expandir a Pesquisa), breast compared (Expandir a Pesquisa), meat compared (Expandir a Pesquisa)
compared law » compared a (Expandir a Pesquisa), compared _ (Expandir a Pesquisa), company law (Expandir a Pesquisa)
nat company » salt company (Expandir a Pesquisa), a company (Expandir a Pesquisa), bad company (Expandir a Pesquisa)
chimp can » chip can (Expandir a Pesquisa), chirp can (Expandir a Pesquisa), camp can (Expandir a Pesquisa)
company a » company _ (Expandir a Pesquisa)
can netw » can new (Expandir a Pesquisa), can net (Expandir a Pesquisa), can newts (Expandir a Pesquisa)
law need » law needs (Expandir a Pesquisa), low need (Expandir a Pesquisa), now need (Expandir a Pesquisa)
d chimp » _ chimp (Expandir a Pesquisa)
j treat » j threat (Expandir a Pesquisa), a treat (Expandir a Pesquisa), j trent (Expandir a Pesquisa)
_ nat » _ net (Expandir a Pesquisa), _ nad (Expandir a Pesquisa), _ nab (Expandir a Pesquisa)
a now » a new (Expandir a Pesquisa), a non (Expandir a Pesquisa), _ now (Expandir a Pesquisa)
treat compared » treated compared (Expandir a Pesquisa), breast compared (Expandir a Pesquisa), meat compared (Expandir a Pesquisa)
compared law » compared a (Expandir a Pesquisa), compared _ (Expandir a Pesquisa), company law (Expandir a Pesquisa)
nat company » salt company (Expandir a Pesquisa), a company (Expandir a Pesquisa), bad company (Expandir a Pesquisa)
chimp can » chip can (Expandir a Pesquisa), chirp can (Expandir a Pesquisa), camp can (Expandir a Pesquisa)
company a » company _ (Expandir a Pesquisa)
can netw » can new (Expandir a Pesquisa), can net (Expandir a Pesquisa), can newts (Expandir a Pesquisa)
law need » law needs (Expandir a Pesquisa), low need (Expandir a Pesquisa), now need (Expandir a Pesquisa)
d chimp » _ chimp (Expandir a Pesquisa)
j treat » j threat (Expandir a Pesquisa), a treat (Expandir a Pesquisa), j trent (Expandir a Pesquisa)
_ nat » _ net (Expandir a Pesquisa), _ nad (Expandir a Pesquisa), _ nab (Expandir a Pesquisa)
a now » a new (Expandir a Pesquisa), a non (Expandir a Pesquisa), _ now (Expandir a Pesquisa)
1
“... was defined as difference in percentages of treated and control subjects who had stopped smoking at one year...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Derry, Sheena, Cording, Malene, Wiffen, Philip J, Law, Simon, Phillips, Tudor, Moore, R Andrew
Publicado no Cochrane Database Syst Rev (2016)
“... analysis was possible, we used dichotomous data to calculate risk ratio and number needed to treat (NNT...”Publicado no Cochrane Database Syst Rev (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Murray, Daniel D., Suzuki, Kazuo, Law, Matthew, Trebicka, Jonel, Neuhaus Nordwall, Jacquie, Johnson, Margaret, Vjecha, Michael J., Kelleher, Anthony D., Emery, Sean
Publicado no Sci Rep (2017)
“... and miR-200a are elevated in ART-treated, HIV-1-infected individuals prior to the development of fatal...”Publicado no Sci Rep (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Yap, Ernie, Law, Zhe Kang, Aslan Abdullah, Nik Muhd, Abdul Wahid, S. Fadilah
Publicado no EXCLI J (2017)
“... is unclear. We performed a systematic review of randomized controlled trials (RCTs) comparing chemotherapy...”Publicado no EXCLI J (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Ware, Matthew J., Krzykawska-Serda, Martyna, Chak-Shing Ho, Jason, Newton, Jared, Suki, Sarah, Law, Justin, Nguyen, Lam, Keshishian, Vazrik, Serda, Maciej, Taylor, Kimberly, Curley, Steven A., Corr, Stuart J.
Publicado no Sci Rep (2017)
“... after treatment when compared to non-heat treated mice. Additionally, we showed that the RF method...”Publicado no Sci Rep (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Zhou, J, Li, PCK, Kumarasamy, N, Boyd, M, Chen, YMA, Sirisanthana, T, Sungkanuparph, S, Oka, S, Tau, G, Phanuphak, P, Saphonn, V, Zhang, FJ, Omar, SFS, Lee, CKC, Ditangco, R, Merati, TP, Lim, PL, Choi, JY, Law, MG, Pujari, S
Publicado em 2009
“... associated with a higher rate of treatment modification after failure. Compared with patients from low-income...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Song, Mingjun, Kwek, Andrew Boon Eu, Law, Ngai Moh, Ong, Jeannie Peng Lan, Tan, Jessica Yi-Lyn, Harichander Thurairajah, Prem, Ang, Daphne Shih Wen, Ang, Tiing Leong
Publicado no World J Gastrointest Pharmacol Ther (2016)
“...% of patients had TMVS of 4 or 5. The number needed to treat was 2.1 to avoid a TMVS of 6 and more...”Publicado no World J Gastrointest Pharmacol Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Willemsen, Koen, Berendes, Thomas D., Geurkink, Timon, Bleys, Ronald L.A.W., Leeflang, Marius A., Weinans, Harrie, Castelein, René M., Nelissen, Rob G.H.H., van der Wal, Bart C.H.
Publicado no J Bone Joint Surg Am (2019)
“...BACKGROUND: Anterior glenohumeral instability with >20% glenoid bone loss is a disorder that can...”Publicado no J Bone Joint Surg Am (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Holmes, Jonathan M., Manny, Ruth E., Lazar, Elizabeth L., Birch, Eileen E., Kelly, Krista R., Summers, Allison I., Martinson, Stacy R., Raghuram, Aparna, Colburn, Jeffrey D., Law, Christine, Marsh, Justin D., Bitner, Derek P., Kraker, Raymond T., Wallace, David K.
Publicado no Ophthalmology (2018)
“... treated with a binocular iPad(®) game plus continued spectacle correction versus continued spectacle...”Publicado no Ophthalmology (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Pijls, B. G., Meessen, J. M. T. A., Schoones, J. W., Fiocco, M., van der Heide, H. J. L., Sedrakyan, A., Nelissen, R. G. H. H.
Publicado no PLoS One (2016)
“...%, 11.2%]; number needed to treat was 12. Further subgroup analyses and meta-regression random effects...”Publicado no PLoS One (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Agwu, Allison L., Warshaw, Meredith G., McFarland, Elizabeth J., Siberry, George K., Melvin, Ann J., Wiznia, Andrew A., Fairlie, Lee, Boyd, Sandra, Harding, Paul, Spiegel, Hans M. L., Abrams, Elaine J., Carey, Vincent J.
Publicado no PLoS One (2017)
“... with limited side effects. P1094 compared the immunologic outcome of continuing failing cART vs. switching to 3...”Publicado no PLoS One (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Eysenbach, Gunther
Publicado em 2005
“... practices around eHealth research, this paper argues for the need for a “science of attrition”, that is, a...”Publicado em 2005
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Al-Kawas, Firas, Aslanian, Harry, Baillie, John, Banovac, Filip, Buscaglia, Jonathan M., Buxbaum, James, Chak, Amitabh, Chong, Bradford, Coté, Gregory A., Draganov, Peter V., Dua, Kulwinder, Durkalski, Valerie, Elmunzer, B. Joseph, Foster, Lydia D., Gardner, Timothy B., Geller, Brian S., Jamidar, Priya, Jamil, Laith H., Keswani, Rajesh N., Khashab, Mouen A., Lang, Gabriel D., Law, Ryan, Lichtenstein, David, Lo, Simon K., McCarthy, Sean, Melo, Silvio, Mullady, Daniel, Nieto, Jose, Bayne Selby, J., Singh, Vikesh K., Spitzer, Rebecca L., Strife, Brian, Tarnaksy, Paul, Taylor, Jason R., Tokar, Jeffrey, Wang, Andrew Y., Williams, April, Willingham, Field, Yachimski, Patrick
Publicado no Trials (2018)
“... malignant hilar obstruction (MHO). METHODS: The INTERCPT trial is a multi-center, comparative effectiveness...”Publicado no Trials (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Harausz, Elizabeth P., Garcia-Prats, Anthony J., Law, Stephanie, Schaaf, H. Simon, Kredo, Tamara, Seddon, James A., Menzies, Dick, Turkova, Anna, Achar, Jay, Amanullah, Farhana, Barry, Pennan, Becerra, Mercedes, Chan, Edward D., Chan, Pei Chun, Ioana Chiotan, Domnica, Crossa, Aldo, Drobac, Peter C., Fairlie, Lee, Falzon, Dennis, Flood, Jennifer, Gegia, Medea, Hicks, Robert M., Isaakidis, Petros, Kadri, SM, Kampmann, Beate, Madhi, Shabir A., Marais, Else, Mariandyshev, Andrei, Méndez-Echevarría, Ana, Moore, Brittany Kathryn, Nargiza, Parpieva, Ozere, Iveta, Padayatchi, Nesri, ur-Rehman, Saleem-, Rybak, Natasha, Santiago-Garcia, Begoña, Shah, N. Sarita, Sharma, Sangeeta, Shim, Tae Sun, Skrahina, Alena, Soriano-Arandes, Antoni, van den Boom, Martin, van der Werf, Marieke J., van der Werf, Tjip S., Williams, Bhanu, Yablokova, Elena, Yim, Jae-Joon, Furin, Jennifer, Hesseling, Anneke C.
Publicado no PLoS Med (2018)
“... for inclusion if it included a minimum of three children (aged <15 years) who were treated for bacteriologically...”Publicado no PLoS Med (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por R. G. Antonio-Carpio, R. G. Antonio-Carpio, M. A. Pérez-Flores, D. Camargo-Guzmán, A. Alanís-Alcantar
Publicado em 2004-01-01
“... this permanent hazard. An association of residents contracted a private company for a geophysical study in order...”Publicado em 2004-01-01
Obter o texto integral
Artigo
16
Por Firas Al-Kawas, Harry Aslanian, John Baillie, Filip Banovac, Jonathan M. Buscaglia, James Buxbaum, Amitabh Chak, Bradford Chong, Gregory A. Coté, Peter V. Draganov, Kulwinder Dua, Valerie Durkalski, B. Joseph Elmunzer, Lydia D. Foster, Timothy B. Gardner, Brian S. Geller, Priya Jamidar, Laith H. Jamil, Rajesh N. Keswani, Mouen A. Khashab, Gabriel D. Lang, Ryan Law, David Lichtenstein, Simon K. Lo, Sean McCarthy, Silvio Melo, Daniel Mullady, Jose Nieto, J. Bayne Selby, Vikesh K. Singh, Rebecca L. Spitzer, Brian Strife, Paul Tarnaksy, Jason R. Taylor, Jeffrey Tokar, Andrew Y. Wang, April Williams, Field Willingham, Patrick Yachimski, In alphabetical order for the INTERCPT Study Group and the United States Cooperative for Outcomes Research in Endoscopy (USCORE)
Publicado em 2018-02-01
“... to suspected malignant hilar obstruction (MHO). Methods The INTERCPT trial is a multi-center, comparative...”Publicado em 2018-02-01
Obter o texto integral
Artigo
17
“... malignancy. However, there is wide variability with regards to need for therapy, time to progressive disease...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Che-Mendoza, Azael, Medina-Barreiro, Anuar, Koyoc-Cardeña, Edgar, Uc-Puc, Valentín, Contreras-Perera, Yamili, Herrera-Bojórquez, Josué, Dzul-Manzanilla, Felipe, Correa-Morales, Fabian, Ranson, Hilary, Lenhart, Audrey, McCall, Philip J., Kroeger, Axel, Vazquez-Prokopec, Gonzalo, Manrique-Saide, Pablo
Publicado no PLoS Negl Trop Dis (2018)
“...BACKGROUND: There is a need for effective methods to control Aedes aegypti and prevent...”Publicado no PLoS Negl Trop Dis (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome
Por Doyle, Jefferson J, Doyle, Alexander J, Wilson, Nicole K, Habashi, Jennifer P, Bedja, Djahida, Whitworth, Ryan E, Lindsay, Mark E, Schoenhoff, Florian, Myers, Loretha, Huso, Nick, Bachir, Suha, Squires, Oliver, Rusholme, Benjamin, Ehsan, Hamid, Huso, David, Thomas, Craig J, Caulfield, Mark J, Van Eyk, Jennifer E, Judge, Daniel P, Dietz, Harry C
Publicado no eLife (2015)
“... in the disorder. Unexpectedly, Marfan mice treated with CCBs show accelerated aneurysm expansion, rupture...”Publicado no eLife (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“... in the chamber containing textiles treated with DDT compared to chambers free of AI. In the field, 57 samples...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo